Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System

BACKGROUND: The dopaminergic partial agonism of the so-called third-generation antipsychotics (TGAs; aripiprazole, brexpiprazole, cariprazine) is hypothesized to cause impulse control disorders (ICDs). Relevant warnings by the Food and Drug Administration (FDA) were posted on aripiprazole (2016) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusaroli, Michele, Raschi, Emanuel, Giunchi, Valentina, Menchetti, Marco, Rimondini Giorgini, Roberto, De Ponti, Fabrizio, Poluzzi, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515127/
https://www.ncbi.nlm.nih.gov/pubmed/35639870
http://dx.doi.org/10.1093/ijnp/pyac031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515127/
https://www.ncbi.nlm.nih.gov/pubmed/35639870
http://dx.doi.org/10.1093/ijnp/pyac031

Ejemplares similares